ArticleMolecular oncology2013

Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives.

Christian Borgo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.